Anika Therapeutics (ANIK) Treasury Shares (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.1 million, up 616.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (up 616.38% YoY), and the FY2025 annual result was $953713.0, up 14.0% from the prior year.
• Treasury Shares rose to $2.1 million in Q1 2026 per ANIK's latest filing, from $953713.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $2.1 million in Q1 2026 and troughed at $53000.0 in Q2 2024.
• A 5-year average of $689992.3 and a median of $712781.0 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares plunged 72.16% in 2023, then jumped 1706.3% in 2025.
• A 5-year view of Treasury Shares shows it stood at $675405.0 in 2022, then sank by 72.16% to $188000.0 in 2023, then surged by 344.98% to $836562.0 in 2024, then climbed by 14.0% to $953713.0 in 2025, then soared by 118.43% to $2.1 million in 2026.
• Business Quant data shows ANIK's Treasury Shares at $2.1 million in Q1 2026, $953713.0 in Q4 2025, and $957338.0 in Q2 2025.